Organization
Laboratoire d’Oncologie Prédictive
1 abstract
Abstract
Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer.Org: Aix Marseille University - Assistance Publique Hopitaux De Marseille, APHM, Service d'Oncologie Multidisciplinaire & Innovations Thérapeutiques, Inserm U1308- CAPTuR- Control of cell Activation in Tumor Progression and Therapeutic Resistance, CNRS UMR 5309-INSERM U1209, CRCM,